Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten Zenz

Showing results (161-170 of 183) with videos related to

Pageof 19
Sort By:
Blood Advances|July 28, 2023
IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemiaCharlotte Syrykh, Berta Pons-Brun, Núria Russiñol, et al.
Leukemia|July 25, 2018
Clonal diversity predicts adverse outcome in chronic lymphocytic leukemiaAlexander C Leeksma, Justin Taylor, Bian Wu, et al.
Blood Cancer Journal|September 23, 2024
Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphomaEce Özoğul, Anna Montaner, Melina Pol, et al.
Cancer Research|March 4, 2017
Recommended Guidelines for Validation, Quality Control, and Reporting of <i>TP53</i> Variants in Clinical PracticeBernard Leroy, Mandy L Ballinger, Fanny Baran-Marszak, et al.
The Lancet. Haematology|November 3, 2023
R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trialMartine E D Chamuleau, Frank Stenner, Dana A Chitu, et al.
Blood|September 19, 2019
Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53Elise Chapiro, Elodie Pramil, M'boyba Diop, et al.
Leukemia|May 5, 2021
Hairy cell leukemia and COVID-19 adaptation of treatment guidelinesMichael Grever, Leslie Andritsos, Versha Banerji, et al.
Leukemia|June 8, 2024
Hairy cell leukemia variant and WHO classification correspondence Re: 5<sup>th</sup> edition WHO classification haematolymphoid tumors: lymphoid neoplasmsMichael Grever, Leslie Andritsos, Mirela Anghelina, et al.
Blood|December 2, 2016
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemiaMichael R Grever, Omar Abdel-Wahab, Leslie A Andritsos, et al.
Nature Communications|May 21, 2016
Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibitionJan A Burger, Dan A Landau, Amaro Taylor-Weiner, et al.
Pageof 19

Showing results (161-170 of 183) with videos related to

Sort By:
Pageof 19
Blood Advances|July 28, 2023
IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemiaCharlotte Syrykh, Berta Pons-Brun, Núria Russiñol, et al.
Leukemia|July 25, 2018
Clonal diversity predicts adverse outcome in chronic lymphocytic leukemiaAlexander C Leeksma, Justin Taylor, Bian Wu, et al.
Blood Cancer Journal|September 23, 2024
Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphomaEce Özoğul, Anna Montaner, Melina Pol, et al.
Cancer Research|March 4, 2017
Recommended Guidelines for Validation, Quality Control, and Reporting of <i>TP53</i> Variants in Clinical PracticeBernard Leroy, Mandy L Ballinger, Fanny Baran-Marszak, et al.
The Lancet. Haematology|November 3, 2023
R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trialMartine E D Chamuleau, Frank Stenner, Dana A Chitu, et al.
Blood|September 19, 2019
Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53Elise Chapiro, Elodie Pramil, M'boyba Diop, et al.
Leukemia|May 5, 2021
Hairy cell leukemia and COVID-19 adaptation of treatment guidelinesMichael Grever, Leslie Andritsos, Versha Banerji, et al.
Leukemia|June 8, 2024
Hairy cell leukemia variant and WHO classification correspondence Re: 5<sup>th</sup> edition WHO classification haematolymphoid tumors: lymphoid neoplasmsMichael Grever, Leslie Andritsos, Mirela Anghelina, et al.
Blood|December 2, 2016
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemiaMichael R Grever, Omar Abdel-Wahab, Leslie A Andritsos, et al.
Nature Communications|May 21, 2016
Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibitionJan A Burger, Dan A Landau, Amaro Taylor-Weiner, et al.
Pageof 19